You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 169 No. 8, April 27, 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular System
 •Quality of Care
 •Patient Safety/ Medical Error
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy
 •Adverse Effects
 •Medication Error
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With Cardiovascular Disease

Michael D. Murray, PharmD, MPH; Mary E. Ritchey, RN, MSPH; Jingwei Wu, MS; Wanzhu Tu, PhD

Arch Intern Med. 2009;169(8):757-763.

Background  Adverse drug events and medication errors are threats to quality care. Inpatient studies suggest that a pharmacist may reduce these events, but outpatient studies have not been forthcoming.

Methods  We conducted a pooled analysis of 2 randomized controlled trials to determine the effect of pharmacist intervention on adverse drug events and medication errors. We studied 800 outpatient cases of hypertension stratified into complicated (n = 535) and uncomplicated (n = 265). Patients in the complicated stratum had heart failure or other cardiovascular complication. Computer programs examined 1-year electronic record data to identify events classified as adverse drug events and preventable or potential adverse drug events. Medication errors included preventable and potential adverse drug events.

Results  Of the 800 participants (mean [SD] age, 59 [10] years), 484 (90.5%) and 258 (97.4%) participants remained in the complicated and uncomplicated strata, respectively, at 12 months. Compared with the control group, the risk of any event was 34% lower in the intervention group (risk ratio, 0.66; 95% confidence interval [CI], 0.50-0.88), including a lower risk of adverse drug events (risk ratio, 0.65; 95% CI, 0.47-0.90), preventable adverse drug events (risk ratio, 0.52; 95% CI, 0.25-1.09), potential adverse drug events (risk ratio, 0.70; 95% CI, 0.40-1.22), and medication errors (risk ratio, 0.63; 95% CI, 0.40-0.98).

Conclusions  This post hoc analysis suggests that pharmacist intervention to improve medication use in outpatients with cardiovascular disease decreases the risk of adverse drug events and medication errors. Further studies are needed to confirm this finding.

Trial Registration  clinicaltrials.gov Identifiers: NCT00388622 and NCT00388817


Author Affiliations: Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy (Dr Murray), and Department of Epidemiology, UNC Gillings School of Public Health (Ms Ritchey), University of North Carolina at Chapel Hill; Divisions of Biostatistics and General Internal Medicine and Geriatrics, School of Medicine, Indiana University School of Medicine (Mr Wu and Dr Tu), Indianapolis; and Regenstrief Institute Inc, Indianapolis (Drs Murray and Tu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Pharmacists Are Key to Enhancing Benefit Risk for Medicines
Anjan K. Banerjee
Arch Intern Med. 2009;169(18):1723.
EXTRACT | FULL TEXT  

Pharmacists Are Key to Enhancing Benefit Risk for Medicines—Reply
Michael D. Murray
Arch Intern Med. 2009;169(18):1723-1724.
EXTRACT | FULL TEXT  

RELATED ARTICLES

The Change We Need in Health Care
David C. Goff, Jr and Philip Greenland
Arch Intern Med. 2009;169(8):737-739.
EXTRACT | FULL TEXT  

Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill
Matthew D. Solomon, Dana P. Goldman, Geoffrey F. Joyce, and José J. Escarce
Arch Intern Med. 2009;169(8):740-748.
ABSTRACT | FULL TEXT  

Prior Authorization for Antidepressants in Medicaid: Effects Among Disabled Dual Enrollees
Alyce S. Adams, Fang Zhang, Robert F. LeCates, Amy Johnson Graves, Dennis Ross-Degnan, Daniel Gilden, Thomas J. McLaughlin, Christine Lu, Connie M. Trinacty, and Stephen B. Soumerai
Arch Intern Med. 2009;169(8):750-756.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors: A Systematic Review and Meta-analysis of Randomized Trials
Santschi et al.
Arch Intern Med 2011;171:1441-1453.
ABSTRACT | FULL TEXT  

Pharmacist Approach to Geriatrics
Hutchison
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2010;4:267-274.
ABSTRACT  

Pharmacists Are Key to Enhancing Benefit Risk for Medicines
Banerjee
Arch Intern Med 2009;169:1723-1723.
FULL TEXT  

Pharmacists Are Key to Enhancing Benefit Risk for Medicines--Reply
Murray
Arch Intern Med 2009;169:1723-1724.
FULL TEXT  

Someone to Watch Over Meds
Journal Watch Cardiology 2009;2009:1-1.
FULL TEXT  

All you need to read in the other general journals
BMJ 2009;338:b1826-b1826.
FULL TEXT  

The Change We Need in Health Care
Goff and Greenland
Arch Intern Med 2009;169:737-739.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.